Global Diabetic Retinopathy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publication Month: Jan 2019 | No. of Pages: 0 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 5220

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.

Scope of the Report:
This report studies the Diabetic Retinopathy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Diabetic Retinopathy market by product type and applications/end industries.
Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.
The global Diabetic Retinopathy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Diabetic Retinopathy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
 Actavis
Alimera Sciences
Ampio Pharmaceuticals
Antisense Therapeutics
BCN Peptides
Boehringer Ingelheim
Glycadia
iCo Therapeutics
Isis Pharmaceuticals
Kowa Group
Lpath
Numoda Capital
Ohr Pharmaceutical
OPKO Health
Parexel International
Promedior
pSivida
Quark Pharmaceuticals
R-Tech Ueno
Sirnaomics
ThromboGenics 

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Laser surgery
Injection of corticosteroids
Anti-VEGF drugs into the eye
Vitrectomy

Market Segment by Applications, can be divided into
Hospitals
Clinics and laboratories
Others

Table of Contents

1 Diabetic Retinopathy Market Overview
1.1 Product Overview and Scope of Diabetic Retinopathy
1.2 Classification of Diabetic Retinopathy by Types
1.2.1 Global Diabetic Retinopathy Revenue Comparison by Types (2017-2023)
1.2.2 Global Diabetic Retinopathy Revenue Market Share by Types in 2017
1.2.3 Laser surgery
1.2.4 Injection of corticosteroids
1.2.5 Anti-VEGF drugs into the eye
1.2.6 Vitrectomy
1.3 Global Diabetic Retinopathy Market by Application
1.3.1 Global Diabetic Retinopathy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics and laboratories
1.3.4 Others
1.4 Global Diabetic Retinopathy Market by Regions
1.4.1 Global Diabetic Retinopathy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Diabetic Retinopathy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Diabetic Retinopathy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetic Retinopathy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Diabetic Retinopathy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetic Retinopathy Status and Prospect (2013-2023)
1.5 Global Market Size of Diabetic Retinopathy (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Diabetic Retinopathy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 Diabetic Retinopathy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Diabetic Retinopathy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Regeneron Pharmaceuticals
2.4.1 Business Overview
2.4.2 Diabetic Retinopathy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Regeneron Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.5  Actavis
2.5.1 Business Overview
2.5.2 Diabetic Retinopathy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3  Actavis Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Alimera Sciences
2.6.1 Business Overview
2.6.2 Diabetic Retinopathy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Alimera Sciences Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ampio Pharmaceuticals
2.7.1 Business Overview
2.7.2 Diabetic Retinopathy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ampio Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Antisense Therapeutics
2.8.1 Business Overview
2.8.2 Diabetic Retinopathy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Antisense Therapeutics Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.9 BCN Peptides
2.9.1 Business Overview
2.9.2 Diabetic Retinopathy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BCN Peptides Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.10 Boehringer Ingelheim
2.10.1 Business Overview
2.10.2 Diabetic Retinopathy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Boehringer Ingelheim Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.11 Glycadia
2.11.1 Business Overview
2.11.2 Diabetic Retinopathy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Glycadia Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.12 iCo Therapeutics
2.12.1 Business Overview
2.12.2 Diabetic Retinopathy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 iCo Therapeutics Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.13 Isis Pharmaceuticals
2.13.1 Business Overview
2.13.2 Diabetic Retinopathy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Isis Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.14 Kowa Group
2.14.1 Business Overview
2.14.2 Diabetic Retinopathy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Kowa Group Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.15 Lpath
2.15.1 Business Overview
2.15.2 Diabetic Retinopathy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Lpath Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.16 Numoda Capital
2.16.1 Business Overview
2.16.2 Diabetic Retinopathy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Numoda Capital Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.17 Ohr Pharmaceutical
2.17.1 Business Overview
2.17.2 Diabetic Retinopathy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Ohr Pharmaceutical Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.18 OPKO Health
2.18.1 Business Overview
2.18.2 Diabetic Retinopathy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 OPKO Health Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.19 Parexel International
2.19.1 Business Overview
2.19.2 Diabetic Retinopathy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Parexel International Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.20 Promedior
2.20.1 Business Overview
2.20.2 Diabetic Retinopathy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Promedior Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.21 pSivida
2.21.1 Business Overview
2.2.2 Diabetic Retinopathy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 pSivida Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.22 Quark Pharmaceuticals
2.22.1 Business Overview
2.22.2 Diabetic Retinopathy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Quark Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.23 R-Tech Ueno
2.23.1 Business Overview
2.23.2 Diabetic Retinopathy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 R-Tech Ueno Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.24 Sirnaomics
2.24.1 Business Overview
2.24.2 Diabetic Retinopathy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Sirnaomics Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
2.25 ThromboGenics 
2.25.1 Business Overview
2.25.2 Diabetic Retinopathy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 ThromboGenics  Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diabetic Retinopathy Market Competition, by Players
3.1 Global Diabetic Retinopathy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetic Retinopathy Players Market Share
3.2.2 Top 10 Diabetic Retinopathy Players Market Share
3.3 Market Competition Trend
4 Global Diabetic Retinopathy Market Size by Regions
4.1 Global Diabetic Retinopathy Revenue and Market Share by Regions
4.2 North America Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
4.3 Europe Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
4.5 South America Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
5 North America Diabetic Retinopathy Revenue by Countries
5.1 North America Diabetic Retinopathy Revenue by Countries (2013-2018)
5.2 USA Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
5.3 Canada Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
5.4 Mexico Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
6 Europe Diabetic Retinopathy Revenue by Countries
6.1 Europe Diabetic Retinopathy Revenue by Countries (2013-2018)
6.2 Germany Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
6.3 UK Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
6.4 France Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
6.5 Russia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
6.6 Italy Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Diabetic Retinopathy Revenue by Countries
7.1 Asia-Pacific Diabetic Retinopathy Revenue by Countries (2013-2018)
7.2 China Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
7.3 Japan Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
7.4 Korea Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
7.5 India Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
8 South America Diabetic Retinopathy Revenue by Countries
8.1 South America Diabetic Retinopathy Revenue by Countries (2013-2018)
8.2 Brazil Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
8.3 Argentina Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
8.4 Colombia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Diabetic Retinopathy by Countries
9.1 Middle East and Africa Diabetic Retinopathy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
9.3 UAE Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
9.4 Egypt Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
9.6 South Africa Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
10 Global Diabetic Retinopathy Market Segment by Type
10.1 Global Diabetic Retinopathy Revenue and Market Share by Type (2013-2018)
10.2 Global Diabetic Retinopathy Market Forecast by Type (2018-2023)
10.3 Laser surgery Revenue Growth Rate (2013-2023)
10.4 Injection of corticosteroids Revenue Growth Rate (2013-2023)
10.5 Anti-VEGF drugs into the eye Revenue Growth Rate (2013-2023)
10.6 Vitrectomy Revenue Growth Rate (2013-2023)
11 Global Diabetic Retinopathy Market Segment by Application
11.1 Global Diabetic Retinopathy Revenue Market Share by Application (2013-2018)
11.2 Diabetic Retinopathy Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics and laboratories Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Diabetic Retinopathy Market Size Forecast (2018-2023)
12.1 Global Diabetic Retinopathy Market Size Forecast (2018-2023)
12.2 Global Diabetic Retinopathy Market Forecast by Regions (2018-2023)
12.3 North America Diabetic Retinopathy Revenue Market Forecast (2018-2023)
12.4 Europe Diabetic Retinopathy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Diabetic Retinopathy Revenue Market Forecast (2018-2023)
12.6 South America Diabetic Retinopathy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Diabetic Retinopathy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

Tables and Figures

List of Tables and Figures

Figure Diabetic Retinopathy Picture
Table Product Specifications of Diabetic Retinopathy
Table Global Diabetic Retinopathy and Revenue (Million USD) Market Split by Product Type
Figure Global Diabetic Retinopathy Revenue Market Share by Types in 2017
Figure Laser surgery Picture
Figure Injection of corticosteroids Picture
Figure Anti-VEGF drugs into the eye Picture
Figure Vitrectomy Picture
Table Global Diabetic Retinopathy Revenue (Million USD) by Application (2013-2023)
Figure Diabetic Retinopathy Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics and laboratories Picture
Figure Others Picture
Table Global Market Diabetic Retinopathy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Diabetic Retinopathy Revenue (Million USD) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Diabetic Retinopathy Type and Applications
Table Bayer Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Diabetic Retinopathy Type and Applications
Table F. Hoffmann-La Roche Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Diabetic Retinopathy Type and Applications
Table Novartis Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Diabetic Retinopathy Type and Applications
Table Regeneron Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table  Actavis Basic Information, Manufacturing Base and Competitors
Table  Actavis Diabetic Retinopathy Type and Applications
Table  Actavis Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table Alimera Sciences Diabetic Retinopathy Type and Applications
Table Alimera Sciences Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Ampio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ampio Pharmaceuticals Diabetic Retinopathy Type and Applications
Table Ampio Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Antisense Therapeutics Basic Information, Manufacturing Base and Competitors
Table Antisense Therapeutics Diabetic Retinopathy Type and Applications
Table Antisense Therapeutics Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table BCN Peptides Basic Information, Manufacturing Base and Competitors
Table BCN Peptides Diabetic Retinopathy Type and Applications
Table BCN Peptides Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Diabetic Retinopathy Type and Applications
Table Boehringer Ingelheim Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Glycadia Basic Information, Manufacturing Base and Competitors
Table Glycadia Diabetic Retinopathy Type and Applications
Table Glycadia Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table iCo Therapeutics Basic Information, Manufacturing Base and Competitors
Table iCo Therapeutics Diabetic Retinopathy Type and Applications
Table iCo Therapeutics Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Isis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Isis Pharmaceuticals Diabetic Retinopathy Type and Applications
Table Isis Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Kowa Group Basic Information, Manufacturing Base and Competitors
Table Kowa Group Diabetic Retinopathy Type and Applications
Table Kowa Group Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Lpath Basic Information, Manufacturing Base and Competitors
Table Lpath Diabetic Retinopathy Type and Applications
Table Lpath Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Numoda Capital Basic Information, Manufacturing Base and Competitors
Table Numoda Capital Diabetic Retinopathy Type and Applications
Table Numoda Capital Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Ohr Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Ohr Pharmaceutical Diabetic Retinopathy Type and Applications
Table Ohr Pharmaceutical Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table OPKO Health Basic Information, Manufacturing Base and Competitors
Table OPKO Health Diabetic Retinopathy Type and Applications
Table OPKO Health Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Parexel International Basic Information, Manufacturing Base and Competitors
Table Parexel International Diabetic Retinopathy Type and Applications
Table Parexel International Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Promedior Basic Information, Manufacturing Base and Competitors
Table Promedior Diabetic Retinopathy Type and Applications
Table Promedior Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table pSivida Basic Information, Manufacturing Base and Competitors
Table pSivida Diabetic Retinopathy Type and Applications
Table pSivida Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Quark Pharmaceuticals Diabetic Retinopathy Type and Applications
Table Quark Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table R-Tech Ueno Basic Information, Manufacturing Base and Competitors
Table R-Tech Ueno Diabetic Retinopathy Type and Applications
Table R-Tech Ueno Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Sirnaomics Basic Information, Manufacturing Base and Competitors
Table Sirnaomics Diabetic Retinopathy Type and Applications
Table Sirnaomics Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table ThromboGenics  Basic Information, Manufacturing Base and Competitors
Table ThromboGenics  Diabetic Retinopathy Type and Applications
Table ThromboGenics  Diabetic Retinopathy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Diabetic Retinopathy Revenue (Million USD) by Players (2013-2018)
Table Global Diabetic Retinopathy Revenue Share by Players (2013-2018)
Figure Global Diabetic Retinopathy Revenue Share by Players in 2016
Figure Global Diabetic Retinopathy Revenue Share by Players in 2017
Figure Global Top 5 Players Diabetic Retinopathy Revenue Market Share in 2017
Figure Global Top 10 Players Diabetic Retinopathy Revenue Market Share in 2017
Figure Global Diabetic Retinopathy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Diabetic Retinopathy Revenue (Million USD) by Regions (2013-2018)
Table Global Diabetic Retinopathy Revenue Market Share by Regions (2013-2018)
Figure Global Diabetic Retinopathy Revenue Market Share by Regions (2013-2018)
Figure Global Diabetic Retinopathy Revenue Market Share by Regions in 2017
Figure North America Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Europe Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure South America Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Table North America Diabetic Retinopathy Revenue by Countries (2013-2018)
Table North America Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure North America Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure North America Diabetic Retinopathy Revenue Market Share by Countries in 2017
Figure USA Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Canada Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Mexico Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Table Europe Diabetic Retinopathy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure Europe Diabetic Retinopathy Revenue Market Share by Countries in 2017
Figure Germany Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure UK Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure France Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Russia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Italy Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Diabetic Retinopathy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Diabetic Retinopathy Revenue Market Share by Countries in 2017
Figure China Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Japan Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Korea Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure India Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Table South America Diabetic Retinopathy Revenue by Countries (2013-2018)
Table South America Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure South America Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure South America Diabetic Retinopathy Revenue Market Share by Countries in 2017
Figure Brazil Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Argentina Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Colombia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Diabetic Retinopathy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Diabetic Retinopathy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Diabetic Retinopathy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure UAE Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Egypt Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure Nigeria Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Figure South Africa Diabetic Retinopathy Revenue and Growth Rate (2013-2018)
Table Global Diabetic Retinopathy Revenue (Million USD) by Type (2013-2018)
Table Global Diabetic Retinopathy Revenue Share by Type (2013-2018)
Figure Global Diabetic Retinopathy Revenue Share by Type (2013-2018)
Figure Global Diabetic Retinopathy Revenue Share by Type in 2017
Table Global Diabetic Retinopathy Revenue Forecast by Type (2018-2023)
Figure Global Diabetic Retinopathy Market Share Forecast by Type (2018-2023)
Figure Global Laser surgery Revenue Growth Rate (2013-2018)
Figure Global Injection of corticosteroids Revenue Growth Rate (2013-2018)
Figure Global Anti-VEGF drugs into the eye Revenue Growth Rate (2013-2018)
Figure Global Vitrectomy Revenue Growth Rate (2013-2018)
Table Global Diabetic Retinopathy Revenue by Application (2013-2018)
Table Global Diabetic Retinopathy Revenue Share by Application (2013-2018)
Figure Global Diabetic Retinopathy Revenue Share by Application (2013-2018)
Figure Global Diabetic Retinopathy Revenue Share by Application in 2017
Table Global Diabetic Retinopathy Revenue Forecast by Application (2018-2023)
Figure Global Diabetic Retinopathy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics and laboratories Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Diabetic Retinopathy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Diabetic Retinopathy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Diabetic Retinopathy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Diabetic Retinopathy Revenue Market Forecast (2018-2023)
Figure Europe Diabetic Retinopathy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Diabetic Retinopathy Revenue Market Forecast (2018-2023)
Figure South America Diabetic Retinopathy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Diabetic Retinopathy Revenue Market Forecast (2018-2023)


Companies Mentioned
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
 Actavis
Alimera Sciences
Ampio Pharmaceuticals
Antisense Therapeutics
BCN Peptides
Boehringer Ingelheim
Glycadia
iCo Therapeutics
Isis Pharmaceuticals
Kowa Group
Lpath
Numoda Capital
Ohr Pharmaceutical
OPKO Health
Parexel International
Promedior
pSivida
Quark Pharmaceuticals
R-Tech Ueno
Sirnaomics
ThromboGenics 

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets